The CNS Regeneration market within the context of Neurology is focused on the development of treatments and therapies to repair or replace damaged or diseased cells in the central nervous system (CNS). This includes treatments for spinal cord injuries, stroke, neurodegenerative diseases, and other neurological disorders. Research and development in this field is driven by the need to improve the quality of life for those affected by neurological conditions.
The CNS Regeneration market is composed of a variety of stakeholders, including pharmaceutical companies, biotechnology companies, academic institutions, and research organizations. These stakeholders are working together to develop innovative treatments and therapies to improve the lives of those affected by neurological conditions.
Some companies in the CNS Regeneration market include Axovant Sciences, BrainStorm Cell Therapeutics, and Neuralstem. Show Less Read more
